For following the competition: what moved in each program, several studies read as one move.
- casdatifan
- tivunatamig
- eb-701
- + 4 more
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Clear-cell metastatic renal cell carcinoma to watchlistEvery Monday by email · turn it off any timePro · free during the beta